Understanding Major Regulatory Change in the Life Sciences Industry
It’s a challenging time for the life sciences industry. With recent fraud and abuse cases involving major pharmaceutical companies making the news, the level of regulatory oversight is unprecedented. Non-compliance with new regulations can result in severe penalties, criminal prosecution and a damaged corporate reputation. Between the Foreign Corrupt Practices Act, the new Physician Payments Sunshine Act, and many other regulations, scrutiny is at an all-time high. What’s a regulatory professional to do? Appian’s here to help.
Please join us for a complimentary one-hour webinar on Monday, August 12. In conjunction with FiercePharma, we’ve put together an all-star panel of regulatory specialists, compliance professionals and industry experts. Speakers include:
- Jay P. Siegel, M.D.
Chief Biotechnology Officer; Head of Scientific Strategy and Policy,
Johnson & Johnson
- Michelle Rohrer, PhD
Vice President of US Regulatory Affairs,
- James Pierce,
Solutions Leader – Pharmaceuticals,
Together, these experts will guide you in navigating the regulatory maze. Dr. Siegel and Dr. Rohrer will talk about the compliance challenges their major corporations have faced, and how you can apply the lessons learned to your own organization. James Pierce will also be on-hand to give a short presentation of the latest technology that aids compliance efforts. If you’ve ever struggled with reporting, operating constraints, or a dizzying array of obscure regulations, this webinar is for you.
If you’re unable to make the webinar, or would like to do some advance reading, we invite you to read our whitepaper for pharma professionals, “The Platform Approach to Solving Compliance Challenges in the Pharmaceutical Industry.” Authored by James Pierce, it’s a great look at how you can think innovatively and leverage state-of-the-art technology in your compliance efforts.
Sr. Manager, Marketing Programs